Search research articles
Contact Us
Filters
Showing results (121-130 of 135) with videos related to
Page
of 14
Sort By:
Cell Reports
|
May 25, 2017
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P Dalvi, Lei Wang, Rui Zhong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 7, 2023
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma
Pingjun Chen, Frank R Rojas, Xin Hu, et al.
Human Pathology
|
August 31, 2017
Thymoma: a clinicopathological correlation of 1470 cases
Annikka Weissferdt, Neda Kalhor, Justin A Bishop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
NPJ Precision Oncology
|
November 18, 2024
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
Alejandra G Serrano, Pedro Rocha, Cibelle Freitas Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
Tina Cascone, Boris Sepesi, Heather Y Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Nature Communications
|
December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics
Ming Tang, Hussein A Abbas, Marcelo V Negrao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma
Minglei Zhuo, Yanfang Guan, Xue Yang, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 135) with videos related to
Sort By:
Page
of 14
Cell Reports
|
May 25, 2017
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P Dalvi, Lei Wang, Rui Zhong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 7, 2023
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma
Pingjun Chen, Frank R Rojas, Xin Hu, et al.
Human Pathology
|
August 31, 2017
Thymoma: a clinicopathological correlation of 1470 cases
Annikka Weissferdt, Neda Kalhor, Justin A Bishop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
NPJ Precision Oncology
|
November 18, 2024
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
Alejandra G Serrano, Pedro Rocha, Cibelle Freitas Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
Tina Cascone, Boris Sepesi, Heather Y Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Nature Communications
|
December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics
Ming Tang, Hussein A Abbas, Marcelo V Negrao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma
Minglei Zhuo, Yanfang Guan, Xue Yang, et al.
Page
of 14